This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Klein, A. L. et al. Phase 3 trial of interleukin-1 trap rilonacept in recurrent pericarditis. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2027892 (2020)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fernández-Ruiz, I. The IL-1 trap rilonacept resolves and prevents recurrent pericarditis. Nat Rev Cardiol 18, 73 (2021). https://doi.org/10.1038/s41569-020-00491-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-020-00491-3